-
公开(公告)号：BE686525A
公开(公告)日：1967-03-07
申请号：BE686525D
申请日：1966-09-07
Applicant: HOFFMANN LA ROCHE
Inventor： FURST A , FURLENMEIER A , LANGEMANN A , WALDVOGEL G , HOCKS P , KERB U , WIECHERT R
-
公开(公告)号：NL6611383A
公开(公告)日：1967-02-14
申请号：NL6611383
申请日：1966-08-12
Applicant: HOFFMANN LA ROCHE
Inventor： FURST A , FURLENMEIER A , LANGEMANN A , WALDVOGEL G , HOCKS P , KERB U , WIECHERT R
-
Patent Agency Ranking
公开(公告)号：SE354653B
公开(公告)日：1973-03-19
申请号：SE1262166
申请日：1962-06-08
Applicant: HOFFMANN LA ROCHE
Inventor： BOLLAG W , GUTMANN H , HEGEDUES B , KAISER A , LANGEMANN A , MUELLER M , ZELLER P
IPC: C07C51/60 , C07C233/00 , C07C243/38 , C07D213/81 , C07D213/82 , C07D261/18 , C07D307/14 , C07D307/52 , C07D317/58 , C07C109/00 , C07C127/22
Abstract: Benzene-ring substituted (2-methylhydrazino)-methyl-benzene compounds and intermediates therefore are described. The former compounds are useful as cytostatic agents and, particularly, inhibit the growth of transplantable tumors in both mice and rats. Thus, they are active, for example, against Walker tumors, Ehrlich carcinoma and Ehrlich ascites carcinoma.
-
公开(公告)号：FI43595B
公开(公告)日：1971-02-01
申请号：FI237166
申请日：1966-09-12
Applicant: HOFFMANN LA ROCHE
Inventor： FUERST A , FURLENMEIER A , WIECHERT R , HOCKS P , KERB U , LANGEMANN A , WALDVOGEL G
-
公开(公告)号：BE685305A
公开(公告)日：1967-02-10
申请号：BE685305D
申请日：1966-08-10
Applicant: HOFFMANN LA ROCHE
Inventor： FURST A , FURLENMEIER A , LANGEMANN A , WALDVOGEL G , HOCKS P , KERB U , WIECHERT R
-
公开(公告)号：DK124479B
公开(公告)日：1972-10-23
申请号：DK446770
申请日：1970-08-31
Applicant: HOFFMANN LA ROCHE
Inventor： FURST A , FURLENMEIER A , LANGEMANN A , WALDVOGEL G , HOCKS P , KERB U , WIECHERT R
-
公开(公告)号：SE342813B
公开(公告)日：1972-02-21
申请号：SE1032966
申请日：1966-07-29
Applicant: HOFFMANN LA ROCHE
Inventor： FUERST A , FURLENMEIER A , HOCKS P , KERB U , LANGEMANN A , WALDVOGEL G , WIECHERT R
-
-
-
-
-
-
Search Results
17
records
(took 0.021 seconds)
